Engineered anti-TSLP antibody This application is filed in US provisional application 61 / 297,008 (filed January 21, 2010) and US provisional application 61 / 258,051 (filed November 4, 2009). ), Each of which is incorporated herein by reference in its entirety.

摘要

The invention relates to binding compounds that specifically bind to human TSLP, as well as uses thereof,e.g.,in the treatment of inflammatory disorders and allergic inflammatory response.